Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $647,172 - $774,803
5,274 Added 48.31%
16,192 $2.31 Million
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $445,608 - $593,154
4,364 Added 66.59%
10,918 $1.4 Million
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $274,049 - $329,214
3,122 Added 90.97%
6,554 $678,000
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $312,106 - $684,821
3,432 New
3,432 $312,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wj Wealth Management, LLC Portfolio

Follow Wj Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wj Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wj Wealth Management, LLC with notifications on news.